Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Personalised breast cancer therapy and the ALLTO trial

26th - 28th Jun 2009

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 16.09.09
Views: 13105

Dr Joanne Zujewski - Head of Breast Cancer Therapeutics, NCI, USA

Dr Joanne Zujewski, Head of Breast Cancer Therapeutics at the National Cancer Institute, USA, talks to ecancer at the 1st IMPAKT meeting about the BIG group, ALLTO trial, personalised medicine and coordinating cross-atlantic research.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation